In 2005 the Riverside Company, a private equity firm acquired Diatron MI PLC, a manufacturer of hematology analyzers as their first step in building a global IVD company. Their vision is to establish Diatron as an industry leading manufacturer supplying small and medium sized laboratories with a complete range of diagnostic instrumentation and reagents.
In staying true to their vision, in 2007 Riverside then acquired Reagent Ltd. to develop the company's own reagent manufacturing facility. Upon that acquisition, Diatron propelled themselves to the enviable and necessary position of being able to offer their customers complete hematology sytems for the first time.
In 2008, Diatron entered the Clinical Chemistry market through a purchase of a manufacturer of automated clinical chemistry analyzers. This represented another major milestone towards completing the company's vision. As a result of Diatron's continuous growth, from 2013 Diatron in Hungary is responsible for manufacturing all automated clinical chemistry analyzers.
Diatron's objective to complete their vision is evident by their commitment to funding their own research and development. In addition, Diatron continues looking for new companies that will further compliment their current product segments. Completing their vision to become a worldwide leading IVD manufacturer that provides its customers with a board portfolio of high-quality systems to fit the customer's needs.